Acorah Software Products - Accounts Production 15.0.600 false true 28 February 2023 1 February 2022 false 1 March 2023 28 February 2024 28 February 2024 13396661 Mr Yashar Alani Mrs Sneha Alani iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13396661 2023-02-28 13396661 2024-02-28 13396661 2023-03-01 2024-02-28 13396661 frs-core:CurrentFinancialInstruments 2024-02-28 13396661 frs-core:Non-currentFinancialInstruments 2024-02-28 13396661 frs-core:ShareCapital 2024-02-28 13396661 frs-core:RetainedEarningsAccumulatedLosses 2024-02-28 13396661 frs-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-28 13396661 frs-bus:FilletedAccounts 2023-03-01 2024-02-28 13396661 frs-bus:SmallEntities 2023-03-01 2024-02-28 13396661 frs-bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-28 13396661 frs-bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-28 13396661 frs-core:UnlistedNon-exchangeTraded 2024-02-28 13396661 frs-core:UnlistedNon-exchangeTraded 2023-02-28 13396661 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-02-28 13396661 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-02-28 13396661 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-02-28 13396661 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-02-28 13396661 frs-bus:Director1 2023-03-01 2024-02-28 13396661 frs-bus:Director2 2023-03-01 2024-02-28 13396661 frs-countries:EnglandWales 2023-03-01 2024-02-28 13396661 2022-01-31 13396661 2023-02-28 13396661 2022-02-01 2023-02-28 13396661 frs-core:CurrentFinancialInstruments 2023-02-28 13396661 frs-core:Non-currentFinancialInstruments 2023-02-28 13396661 frs-core:ShareCapital 2023-02-28 13396661 frs-core:RetainedEarningsAccumulatedLosses 2023-02-28
Registered number: 13396661
Little Balthazar Pharma Ltd
Unaudited Financial Statements
For The Year Ended 28 February 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 13396661
28 February 2024 28 February 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 3,193,281 3,193,281
3,193,281 3,193,281
CURRENT ASSETS
Debtors 5 163 15,863
Cash at bank and in hand 1,018 285
1,181 16,148
Creditors: Amounts Falling Due Within One Year 6 (693,767 ) (687,367 )
NET CURRENT ASSETS (LIABILITIES) (692,586 ) (671,219 )
TOTAL ASSETS LESS CURRENT LIABILITIES 2,500,695 2,522,062
Creditors: Amounts Falling Due After More Than One Year 7 (2,311,522 ) (2,441,656 )
NET ASSETS 189,173 80,406
CAPITAL AND RESERVES
Called up share capital 8 100 100
Profit and Loss Account 189,073 80,306
SHAREHOLDERS' FUNDS 189,173 80,406
Page 1
Page 2
For the year ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Yashar Alani
Director
17/08/2024
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Little Balthazar Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13396661 . The registered office is 4 Nutter Lane, London, E11 2HY.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
4. Investments
Unlisted
£
Cost
As at 1 March 2023 3,193,281
As at 28 February 2024 3,193,281
Provision
As at 1 March 2023 -
As at 28 February 2024 -
Net Book Value
As at 28 February 2024 3,193,281
As at 1 March 2023 3,193,281
5. Debtors
28 February 2024 28 February 2023
£ £
Due within one year
Amounts owed by subsidiaries 163 15,863
6. Creditors: Amounts Falling Due Within One Year
28 February 2024 28 February 2023
£ £
Other creditors 480,514 557,429
Accruals and deferred income 2,000 2,000
Amounts owed to subsidiaries 211,253 127,938
693,767 687,367
7. Creditors: Amounts Falling Due After More Than One Year
28 February 2024 28 February 2023
£ £
Bank loans 2,311,522 2,441,656
Page 3
Page 4
8. Share Capital
28 February 2024 28 February 2023
£ £
Allotted, Called up and fully paid 100 100
Page 4